APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Women's Health Care Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Women's Health Care Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174047770331 December 2025190 pages

Choose your research edition.

Industry ResearchWomen's Health Care Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Women's Health Care Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Women's Health Care Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Women's Health Care Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Women's Health Care Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Women's Health Care Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Women's Health Care Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Women's Health Care Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Women's Health Care Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Women's Health Care Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Women's Health Care Drugs include Merck & Co, Mylan N.V., Lupin, Pfizer Inc., Ferring Pharmaceuticals, Bayer AG, Amgen, Allergan and Blairex Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Women's Health Care Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Women's Health Care Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Women's Health Care Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Women's Health Care Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Women's Health Care Drugs Segment by Company

Merck & Co

Mylan N.V.

Lupin

Pfizer Inc.

Ferring Pharmaceuticals

Bayer AG

Amgen

Allergan

Blairex Laboratories

Apothecus Pharmaceutical

Agile Therapeutics

Women's Health Care Drugs Segment by Type

Endometriosis

Postmenopausal Osteoporosis

Menopause

Hormonal Infertility

Polycystic Ovary Syndrome

Contraceptives

Others

Women's Health Care Drugs Segment by Application

Prescription Drugs

Non-prescription Drugs

Women's Health Care Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women's Health Care Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Women's Health Care Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women's Health Care Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Women's Health Care Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Women's Health Care Drugs industry.

Chapter 3: Detailed analysis of Women's Health Care Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Women's Health Care Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Women's Health Care Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Endometriosis Table 3. Key Players of Postmenopausal Osteoporosis Table 4. Key Players of Menopause Table 3. Key Players of Hormonal Infertility Table 4. Key Players of Polycystic Ovary Syndrome Table 5. Key Players of Contraceptives Table 6. Key Players of Others Table 7. Global Women's Health Care Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 8. Key Players of Prescription Drugs Table 9. Key Players of Non-prescription Drugs Table 10. Global Women's Health Care Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Women's Health Care Drugs Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Women's Health Care Drugs Market Share by Region (2021-2026) Table 13. Global Women's Health Care Drugs Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Women's Health Care Drugs Market Share by Region (2027-2032) Table 15. Women's Health Care Drugs Industry Trends Table 16. Women's Health Care Drugs Industry Drivers Table 17. Women's Health Care Drugs Industry Opportunities and Challenges Table 18. Women's Health Care Drugs Industry Restraints Table 19. Global Women's Health Care Drugs Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Women's Health Care Drugs Revenue Market Share by Company (2021-2026) Table 21. Global Women's Health Care Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Women's Health Care Drugs Key Company Head Office and Area Served Table 23. Global Women's Health Care Drugs Company, Product Type & Application Table 24. Global Women's Health Care Drugs Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Women's Health Care Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Women's Health Care Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Women's Health Care Drugs Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Women's Health Care Drugs Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Women's Health Care Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Women's Health Care Drugs Revenue Market Share by Type (2027-2032) Table 32. Global Women's Health Care Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Women's Health Care Drugs Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Women's Health Care Drugs Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Women's Health Care Drugs Revenue Market Share by Application (2021-2026) Table 36. Global Women's Health Care Drugs Revenue Market Share by Application (2027-2032) Table 37. Merck & Co Company Information Table 38. Merck & Co Business Overview Table 39. Merck & Co Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Merck & Co Women's Health Care Drugs Product Portfolio Table 41. Merck & Co Recent Development Table 42. Mylan N.V. Company Information Table 43. Mylan N.V. Business Overview Table 44. Mylan N.V. Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Mylan N.V. Women's Health Care Drugs Product Portfolio Table 46. Mylan N.V. Recent Development Table 47. Lupin Company Information Table 48. Lupin Business Overview Table 49. Lupin Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Lupin Women's Health Care Drugs Product Portfolio Table 51. Lupin Recent Development Table 52. Pfizer Inc. Company Information Table 53. Pfizer Inc. Business Overview Table 54. Pfizer Inc. Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Pfizer Inc. Women's Health Care Drugs Product Portfolio Table 56. Pfizer Inc. Recent Development Table 57. Ferring Pharmaceuticals Company Information Table 58. Ferring Pharmaceuticals Business Overview Table 59. Ferring Pharmaceuticals Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Ferring Pharmaceuticals Women's Health Care Drugs Product Portfolio Table 61. Ferring Pharmaceuticals Recent Development Table 62. Bayer AG Company Information Table 63. Bayer AG Business Overview Table 64. Bayer AG Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Bayer AG Women's Health Care Drugs Product Portfolio Table 66. Bayer AG Recent Development Table 67. Amgen Company Information Table 68. Amgen Business Overview Table 69. Amgen Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Amgen Women's Health Care Drugs Product Portfolio Table 71. Amgen Recent Development Table 72. Allergan Company Information Table 73. Allergan Business Overview Table 74. Allergan Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Allergan Women's Health Care Drugs Product Portfolio Table 76. Allergan Recent Development Table 77. Blairex Laboratories Company Information Table 78. Blairex Laboratories Business Overview Table 79. Blairex Laboratories Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Blairex Laboratories Women's Health Care Drugs Product Portfolio Table 81. Blairex Laboratories Recent Development Table 82. Apothecus Pharmaceutical Company Information Table 83. Apothecus Pharmaceutical Business Overview Table 84. Apothecus Pharmaceutical Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Apothecus Pharmaceutical Women's Health Care Drugs Product Portfolio Table 86. Apothecus Pharmaceutical Recent Development Table 87. Agile Therapeutics Company Information Table 88. Agile Therapeutics Business Overview Table 89. Agile Therapeutics Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Agile Therapeutics Women's Health Care Drugs Product Portfolio Table 91. Agile Therapeutics Recent Development Table 92. North America Women's Health Care Drugs Market Size by Type (2021-2026) & (US$ Million) Table 93. North America Women's Health Care Drugs Market Size by Type (2027-2032) & (US$ Million) Table 94. North America Women's Health Care Drugs Market Size by Application (2021-2026) & (US$ Million) Table 95. North America Women's Health Care Drugs Market Size by Application (2027-2032) & (US$ Million) Table 96. North America Women's Health Care Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Women's Health Care Drugs Market Size by Country (2021-2026) Table 98. North America Women's Health Care Drugs Market Size by Country (2027-2032) Table 99. Europe Women's Health Care Drugs Market Size by Type (2021-2026) & (US$ Million) Table 100. Europe Women's Health Care Drugs Market Size by Type (2027-2032) & (US$ Million) Table 101. Europe Women's Health Care Drugs Market Size by Application (2021-2026) & (US$ Million) Table 102. Europe Women's Health Care Drugs Market Size by Application (2027-2032) & (US$ Million) Table 103. Europe Women's Health Care Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Women's Health Care Drugs Market Size by Country (2021-2026) Table 105. Europe Women's Health Care Drugs Market Size by Country (2027-2032) Table 106. China Women's Health Care Drugs Market Size by Type (2021-2026) & (US$ Million) Table 107. China Women's Health Care Drugs Market Size by Type (2027-2032) & (US$ Million) Table 108. China Women's Health Care Drugs Market Size by Application (2021-2026) & (US$ Million) Table 109. China Women's Health Care Drugs Market Size by Application (2027-2032) & (US$ Million) Table 110. Asia Women's Health Care Drugs Market Size by Type (2021-2026) & (US$ Million) Table 111. Asia Women's Health Care Drugs Market Size by Type (2027-2032) & (US$ Million) Table 112. Asia Women's Health Care Drugs Market Size by Application (2021-2026) & (US$ Million) Table 113. Asia Women's Health Care Drugs Market Size by Application (2027-2032) & (US$ Million) Table 114. Asia Women's Health Care Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Asia Women's Health Care Drugs Market Size by Country (2021-2026) Table 116. Asia Women's Health Care Drugs Market Size by Country (2027-2032) Table 117. South America, Middle East & Africa Women's Health Care Drugs Market Size by Type (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Women's Health Care Drugs Market Size by Type (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Women's Health Care Drugs Market Size by Application (2021-2026) & (US$ Million) Table 120. South America, Middle East & Africa Women's Health Care Drugs Market Size by Application (2027-2032) & (US$ Million) Table 121. South America, Middle East & Africa Women's Health Care Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. South America, Middle East & Africa Women's Health Care Drugs Market Size by Country (2021-2026) Table 123. South America, Middle East & Africa Women's Health Care Drugs Market Size by Country (2027-2032) Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Women's Health Care Drugs Product Image Figure 2. Global Women's Health Care Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Women's Health Care Drugs Market Share by Type: 2025 VS 2032 Figure 4. Endometriosis Image Figure 5. Postmenopausal Osteoporosis Image Figure 6. Menopause Image Figure 7. Hormonal Infertility Image Figure 8. Polycystic Ovary Syndrome Image Figure 9. Contraceptives Image Figure 10. Others Image Figure 11. Global Women's Health Care Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 12. Global Women's Health Care Drugs Market Share by Application: 2025 VS 2032 Figure 13. Prescription Drugs Image Figure 14. Non-prescription Drugs Image Figure 15. Global Women's Health Care Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 17. Global Women's Health Care Drugs Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Women's Health Care Drugs Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Women's Health Care Drugs Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Women's Health Care Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Women's Health Care Drugs Revenue Market Share by Type (2021-2032) Figure 24. Global Women's Health Care Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Women's Health Care Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 27. North America Women's Health Care Drugs Market Share by Type (2021-2032) Figure 28. North America Women's Health Care Drugs Market Share by Application (2021-2032) Figure 29. North America Women's Health Care Drugs Market Share by Country (2021-2032) Figure 30. United States Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Canada Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 33. Europe Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 34. Europe Women's Health Care Drugs Market Share by Type (2021-2032) Figure 35. Europe Women's Health Care Drugs Market Share by Application (2021-2032) Figure 36. Europe Women's Health Care Drugs Market Share by Country (2021-2032) Figure 37. Germany Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 38. France Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Italy Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 41. Russia Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 43. China Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 44. China Women's Health Care Drugs Market Share by Type (2021-2032) Figure 45. China Women's Health Care Drugs Market Share by Application (2021-2032) Figure 46. Asia Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 47. Asia Women's Health Care Drugs Market Share by Type (2021-2032) Figure 48. Asia Women's Health Care Drugs Market Share by Application (2021-2032) Figure 49. Asia Women's Health Care Drugs Market Share by Country (2021-2032) Figure 50. Japan Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 54. India Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 55. Australia Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Women's Health Care Drugs Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Women's Health Care Drugs Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Women's Health Care Drugs Market Share by Country (2021-2032) Figure 60. Brazil Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 65. UAE Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 67. Chile Women's Health Care Drugs Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Endometriosis
  • Postmenopausal Osteoporosis
  • Menopause
  • Hormonal Infertility
  • Polycystic Ovary Syndrome
  • Contraceptives
  • Others
Applications
  • Prescription Drugs
  • Non-prescription Drugs
Companies covered
  • Merck & Co
  • Mylan N.V.
  • Lupin
  • Pfizer Inc.
  • Ferring Pharmaceuticals
  • Bayer AG
  • Amgen
  • Allergan
  • Blairex Laboratories
  • Apothecus Pharmaceutical
  • Agile Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Women's Health Care Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Endometriosis
  5. 1.2.3 Postmenopausal Osteoporosis
  6. 1.2.4 Menopause
  7. 1.2.5 Hormonal Infertility
  8. 1.2.6 Polycystic Ovary Syndrome
  9. 1.2.7 Contraceptives
  10. 1.2.8 Others
  11. 1.3 Market Analysis by Application
  12. 1.3.1 Global Women's Health Care Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  13. 1.3.2 Prescription Drugs
  14. 1.3.3 Non-prescription Drugs
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Women's Health Care Drugs Growth Trends by Region
  17. 1.5.1 Global Women's Health Care Drugs Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Women's Health Care Drugs Market Size by Region (2021-2026)
  19. 1.5.3 Women's Health Care Drugs Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Women's Health Care Drugs Market Dynamics
  1. 2.1 Women's Health Care Drugs Industry Trends
  2. 2.2 Women's Health Care Drugs Industry Drivers
  3. 2.3 Women's Health Care Drugs Industry Opportunities and Challenges
  4. 2.4 Women's Health Care Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Women's Health Care Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Women's Health Care Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Women's Health Care Drugs Key Company Head office and Area Served
  4. 3.4 Global Women's Health Care Drugs Company, Product Type & Application
  5. 3.5 Global Women's Health Care Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Women's Health Care Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Women's Health Care Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Women's Health Care Drugs Tier 1, Tier 2, and Tier 3
4 Women's Health Care Drugs Market by Type
  1. 4.1 Global Women's Health Care Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Women's Health Care Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Women's Health Care Drugs Market Size Share by Type (2021-2032)
5 Women's Health Care Drugs Market by Application
  1. 5.1 Global Women's Health Care Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Women's Health Care Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Women's Health Care Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck & Co
  2. 6.1.1 Merck & Co Company Information
  3. 6.1.2 Merck & Co Business Overview
  4. 6.1.3 Merck & Co Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Merck & Co Women's Health Care Drugs Product Portfolio
  6. 6.1.5 Merck & Co Recent Developments
  7. 6.2 Mylan N.V.
  8. 6.2.1 Mylan N.V. Company Information
  9. 6.2.2 Mylan N.V. Business Overview
  10. 6.2.3 Mylan N.V. Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Mylan N.V. Women's Health Care Drugs Product Portfolio
  12. 6.2.5 Mylan N.V. Recent Developments
  13. 6.3 Lupin
  14. 6.3.1 Lupin Company Information
  15. 6.3.2 Lupin Business Overview
  16. 6.3.3 Lupin Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Lupin Women's Health Care Drugs Product Portfolio
  18. 6.3.5 Lupin Recent Developments
  19. 6.4 Pfizer Inc.
  20. 6.4.1 Pfizer Inc. Company Information
  21. 6.4.2 Pfizer Inc. Business Overview
  22. 6.4.3 Pfizer Inc. Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Inc. Women's Health Care Drugs Product Portfolio
  24. 6.4.5 Pfizer Inc. Recent Developments
  25. 6.5 Ferring Pharmaceuticals
  26. 6.5.1 Ferring Pharmaceuticals Company Information
  27. 6.5.2 Ferring Pharmaceuticals Business Overview
  28. 6.5.3 Ferring Pharmaceuticals Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Ferring Pharmaceuticals Women's Health Care Drugs Product Portfolio
  30. 6.5.5 Ferring Pharmaceuticals Recent Developments
  31. 6.6 Bayer AG
  32. 6.6.1 Bayer AG Company Information
  33. 6.6.2 Bayer AG Business Overview
  34. 6.6.3 Bayer AG Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bayer AG Women's Health Care Drugs Product Portfolio
  36. 6.6.5 Bayer AG Recent Developments
  37. 6.7 Amgen
  38. 6.7.1 Amgen Company Information
  39. 6.7.2 Amgen Business Overview
  40. 6.7.3 Amgen Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Amgen Women's Health Care Drugs Product Portfolio
  42. 6.7.5 Amgen Recent Developments
  43. 6.8 Allergan
  44. 6.8.1 Allergan Company Information
  45. 6.8.2 Allergan Business Overview
  46. 6.8.3 Allergan Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Allergan Women's Health Care Drugs Product Portfolio
  48. 6.8.5 Allergan Recent Developments
  49. 6.9 Blairex Laboratories
  50. 6.9.1 Blairex Laboratories Company Information
  51. 6.9.2 Blairex Laboratories Business Overview
  52. 6.9.3 Blairex Laboratories Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Blairex Laboratories Women's Health Care Drugs Product Portfolio
  54. 6.9.5 Blairex Laboratories Recent Developments
  55. 6.10 Apothecus Pharmaceutical
  56. 6.10.1 Apothecus Pharmaceutical Company Information
  57. 6.10.2 Apothecus Pharmaceutical Business Overview
  58. 6.10.3 Apothecus Pharmaceutical Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Apothecus Pharmaceutical Women's Health Care Drugs Product Portfolio
  60. 6.10.5 Apothecus Pharmaceutical Recent Developments
  61. 6.11 Agile Therapeutics
  62. 6.11.1 Agile Therapeutics Company Information
  63. 6.11.2 Agile Therapeutics Business Overview
  64. 6.11.3 Agile Therapeutics Women's Health Care Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Agile Therapeutics Women's Health Care Drugs Product Portfolio
  66. 6.11.5 Agile Therapeutics Recent Developments
7 North America
  1. 7.1 North America Women's Health Care Drugs Market Size (2021-2032)
  2. 7.2 North America Women's Health Care Drugs Market Size by Type
  3. 7.2.1 North America Women's Health Care Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Women's Health Care Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Women's Health Care Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Women's Health Care Drugs Market Size by Application
  7. 7.3.1 North America Women's Health Care Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Women's Health Care Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Women's Health Care Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Women's Health Care Drugs Market Size by Country
  11. 7.4.1 North America Women's Health Care Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Women's Health Care Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Women's Health Care Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Women's Health Care Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Women's Health Care Drugs Market Size (2021-2032)
  2. 8.2 Europe Women's Health Care Drugs Market Size by Type
  3. 8.2.1 Europe Women's Health Care Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Women's Health Care Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Women's Health Care Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Women's Health Care Drugs Market Size by Application
  7. 8.3.1 Europe Women's Health Care Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Women's Health Care Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Women's Health Care Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Women's Health Care Drugs Market Size by Country
  11. 8.4.1 Europe Women's Health Care Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Women's Health Care Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Women's Health Care Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Women's Health Care Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Women's Health Care Drugs Market Size (2021-2032)
  2. 9.2 China Women's Health Care Drugs Market Size by Type
  3. 9.2.1 China Women's Health Care Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Women's Health Care Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Women's Health Care Drugs Market Share by Type (2021-2032)
  6. 9.3 China Women's Health Care Drugs Market Size by Application
  7. 9.3.1 China Women's Health Care Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Women's Health Care Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Women's Health Care Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Women's Health Care Drugs Market Size (2021-2032)
  2. 10.2 Asia Women's Health Care Drugs Market Size by Type
  3. 10.2.1 Asia Women's Health Care Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Women's Health Care Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Women's Health Care Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Women's Health Care Drugs Market Size by Application
  7. 10.3.1 Asia Women's Health Care Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Women's Health Care Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Women's Health Care Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Women's Health Care Drugs Market Size by Country
  11. 10.4.1 Asia Women's Health Care Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Women's Health Care Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Women's Health Care Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Women's Health Care Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Women's Health Care Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Women's Health Care Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Women's Health Care Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Women's Health Care Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Women's Health Care Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Women's Health Care Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Women's Health Care Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Women's Health Care Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Women's Health Care Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Women's Health Care Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Women's Health Care Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Women's Health Care Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Women's Health Care Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Women's Health Care Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst